Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Dow
Merck
Baxter
Moodys
Colorcon
McKinsey

Last Updated: December 7, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for ASP2151

See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug ASP2151?

ASP2151 is an investigational drug.

There have been 13 clinical trials for ASP2151. The most recent clinical trial was a Phase 3 trial, which was initiated on August 1st 2013.

The most common disease conditions in clinical trials are Herpes Zoster, Herpes Simplex, and Herpes Genitalis. The leading clinical trial sponsors are Maruho Europe Limited, Astellas Pharma Inc, and Maruho Co., Ltd.

There are two US patents protecting this investigational drug and thirty-two international patents.

Recent Clinical Trials for ASP2151
TitleSponsorPhase
Drug-Drug Interaction Study: ASP2151 and MidazolamMaruho Europe LimitedPhase 1
Drug-Drug Interaction Study: ASP2151 and BupropionMaruho Europe LimitedPhase 1
Drug-Drug Interaction Study: ASP2151 and MontelukastMaruho Europe LimitedPhase 1

See all ASP2151 clinical trials

Clinical Trial Summary for ASP2151

Top disease conditions for ASP2151
Top clinical trial sponsors for ASP2151

See all ASP2151 clinical trials

US Patents for ASP2151

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
ASP2151   Start Trial Tetrahydro-2H-thiopyran-4-carboxamide derivative Yamanouchi Pharmaceutical Co., Ltd. (Tokyo, JP) Rational Drug Design Laboratories (Tokyo, JP)   Start Trial
ASP2151   Start Trial Amido derivatives-contained pharmaceutical composition ASTELLAS PHARMA INC. (Tokyo, JP)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School
Mallinckrodt
Merck
AstraZeneca
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.